SELLAS Life Sciences Group, Inc. — Director's Dealing 2013

Feb 1, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Galena Biopharma, Inc. (GALE)
CIK: 0001390478
Period of Report: 2013-01-29

Reporting Person: Nisi Rudolph (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-01-29	Stock Option (right to buy)	$1.71	A	50000	Acquired	2023-01-29	Common Stock (50000)	Direct

Footnotes

F1: Granted pursuant to the Issuer's Amended and Restated 2007 Incentive Plan.

F2: The options will vest in equal quarterly installments of 12,500 shares on each of April 29, 2013, July 29, 2013, October 29, 2013 and January 29, 2014.